George Marzloff, MD
I am a physician specializing in Rehabilitation Medicine with a focus on Assistive Technology
Developing digital signal processing algorithms to measure realtime heart rate and blood pressure from implanted functional electrical stimulation systems.
SinaiMedMaker hackathon project that uses biofeedback to wirelessly control parameters of a patient's environment such as lighting and ambient sound as well as trigger actions to a computer. Team members were Jen Lewin, Bill Magnuson, Austin Puckett, Andrew Abdou, and Salman Hirani.
Currently in design and prototype stage. Clinical trial pending.
I publish stories on Medium and contribute to the Association of Academic Physiatrists News publication.
There is a saying that learning in medical school is like “drinking from a firehose.” I have also heard estimates that one learns [insert some large number here] of new words in medical school, but they were never substantiated by data...
Electromyography (EMG) is a method to evaluate motor unit action potential activity in a muscle region. As action potentials (electrical signals) propagate through nerves to neuromuscular junctions, the change in electrical potentials (voltage) can be measured...
Research in using technology for rehabilitation is a burgeoning field. Many exciting high-tech devices such as bionic limbs and exoskeletons are in development with funding from large grant sources such as the Defense Advanced Research Projects Agency...
Research can be a daunting task to add onto a busy residency or fellowship training schedule. Cases, retrospective studies, and review articles use existing data and require little to no involvement of an institutional review board (IRB), and thus can yield a manuscript faster than prospective studies...
Recruited patients for national clinical trials, administered cognitive testing and collected data, prepared IRB/NIH submissions, and maintained regulatory documents. Analyzed safety, tolerability, and pharmacokinetic data for nutraceutical study. Served as liaison between the research center and the national Alzheimer’s Disease Cooperative Society.
Performed dietary experimentation in rats and gerbils to study neuroprotective benefits of chronic supplementation of uridine and docosahexaenoic acid (DHA). Co-authored articles related to the effects of polyunsaturated fatty acids (e.g. DHA) on synaptic membrane synthesis in gerbils and rats. This animal research led to the active clinical trials of Souvenaid in U.S. and Europe as a possible treatment for cognitive decline in the elderly.
Performed dietary experimentation in rats and gerbils to study neuroprotective benefits of chronic supplementation of uridine and docosahexaenoic acid.
Designed and programmed computer-based cognitive experiments, and analyzed data to construct computational models of thought processes.